# Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients

> **NCT06629714** · — · COMPLETED · sponsor: **Anhui Medical University** · enrollment: 196 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Immune Checkpoint Inhibitors
- Inflammation
- Cancer, Treatment-Related
- Emotional Distress
- Gastroesophageal Cancer (GC)
- Biomarkers / Blood
- Progression-free Survival, PFS

## Interventions

- **OTHER:** Exposure: emotional distress status

## Key facts

- **NCT ID:** NCT06629714
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-16
- **Primary completion:** 2025-04-20
- **Final completion:** 2025-04-20
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629714, "Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06629714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*